A Research Study on Cognitive Health Benefits of Nicotine to the Human Body

Year : 2025 | Volume : | : | Page : –
By
vector

Mekkanti Manasa Rekha,

vector

Mekkanti Manasa Rekha,

  1. Associate Professor, Department of Pharmacy Practice, Aditya Bangalore Institute of Pharmacy Education and Research, Bangalore, Karnataka, India
  2. Pharm.D student, Department of Pharmacy Practice, Aditya Bangalore Institute of Pharmacy Education and Research, Bangalore, Karnataka, India

Abstract

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_abs_149393’);});Edit Abstract & Keyword

Background: Nicotine has been primarily known for its addictive properties and associated health risks, particularly in tobacco products. However, recent research has highlighted nicotine’s potential cognitive health benefits, especially in neurodegenerative diseases like Alzheimer’s and Parkinson’s. This study investigates smoking prevalence across mental health conditions, cognitive impairments in various psychiatric disorders, and explores the possible cognitive health benefits of nicotine. Methods: Data on age and gender distribution, smoking prevalence, and cognitive impairments were analyzed. The study also utilized meta-analyses to examine the effect sizes of cognitive deficits in different mental health conditions, including schizophrenia, bipolar disorder, major depressive disorder, PTSD, ADHD, and substance use disorders. Additionally, p-value calculations were conducted to evaluate the statistical significance of the observed differences. Results: Population Distribution Males represented 91.87% of the population, with the majority falling within the 18-30 age group. Females made up only 8.12%, predominantly in the 18-30 age group. Smoking Prevalence The highest smoking prevalence was observed among individuals with substance use disorders (SUD), particularly opiate users (>98%) and cocaine users (80-90%). Schizophrenia showed smoking rates ranging from 54-89%, while bipolar disorder, major depressive disorder, PTSD, and ADHD exhibited substantial smoking rates (50-70%). Cognitive Deficits Schizophrenia displayed large deficits in executive functioning, working memory, attention/vigilance, episodic memory, and language. Bipolar disorder and major depressive disorder showed moderate deficits in working memory, attention, and processing speed. PTSD had severe deficits in verbal memory, while ADHD and substance use disorders exhibited moderate deficits in working memory, attention, language, and cognitive impulsivity. Nicotine’s Cognitive Benefits, Nicotine was found to enhance memory and cognitive function through modulation of key brain pathways, such as the phosphoinositide 3-kinase/Akt pathway and thyroid receptor signaling. It also promotes synaptic plasticity via chromatin modification and protein kinase activation. P-Value Analysis: The calculated p-value (0.1336) was greater than the significance level (α = 0.05), indicating that the observed associations were not statistically significant. Conclusions: Nicotine has shown potential cognitive health benefits, particularly in individuals with neurodegenerative conditions. However, its cognitive-enhancing effects must be weighed against the risks associated with smoking and nicotine addiction. The study highlights the need for further research on controlled, non-addictive nicotine delivery methods to explore its therapeutic applications safely. Addressing research gaps related to long-term cognitive effects, nicotine delivery methods, and diverse population studies will contribute to a more nuanced understanding of nicotine’s role in cognitive health.

Keywords: Nicotine, smoking prevalence, cognitive deficits, psychiatric disorders, neurodegenerative diseases, cognitive health benefits, substance use disorders, mental health.

How to cite this article:
Mekkanti Manasa Rekha, Mekkanti Manasa Rekha. A Research Study on Cognitive Health Benefits of Nicotine to the Human Body. Research & Reviews: A Journal of Drug Design & Discovery. 2025; ():-.
How to cite this URL:
Mekkanti Manasa Rekha, Mekkanti Manasa Rekha. A Research Study on Cognitive Health Benefits of Nicotine to the Human Body. Research & Reviews: A Journal of Drug Design & Discovery. 2025; ():-. Available from: https://journals.stmjournals.com/rrjoddd/article=2025/view=0

document.addEventListener(‘DOMContentLoaded’,function(){frmFrontForm.scrollToID(‘frm_container_ref_149393’);});Edit

References

  1. P.A., Potter, A., & Singh, A. (2004). Nicotine and nicotinic receptor involvement in neuropsychiatric disorders. Current Topics in Medicinal Chemistry, 4(3), 267-282. DOI:10.2174/1568026043451401
  2. Levin, E.D., & Rezvani, A.H. (2002).Nicotinic treatment for cognitive dysfunction. Current Drug Targets – CNS & Neurological Disorders, 4(1),423-431 DOI:10.2174/1568007023339102 .
  3. Quik, M., & Kulak, J.M. (2002). Nicotine and nicotinic receptors: relevance to Parkinson’s disease. Neurotoxicology, 23(4-5), 581-594. https://doi.org/10.1016/S0161-813X(02)00036-0
  4. Mahmoudzadeh L, Abtahi Froushani SM, Ajami M, Mahmoudzadeh M. Effect of Nicotine on Immune System Function. Adv Pharm Bull. 2023 Jan;13(1):69-78. doi: 10.34172/apb.2023.008.
  5. Audrain‐McGovern J, Benowitz NL. Cigarette smoking, nicotine, and body weight. Clinical Pharmacology & Therapeutics. 2011 Jul;90(1):164-8. doi:10.1038/clpt.2011.105 .
  6. Ripoll N, Bronnec M, Bourin M. Nicotinic receptors and schizophrenia. Curr Med Res Opin. 2004 Jul;20(7):1057-74. doi: 10.1185/030079904125004060.
  7. Potter, A.S., Newhouse, P.A. Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder. Psychopharmacology176, 183–194 (2004). https://doi.org/10.1007/s00213-004-1874-y
  8. Jamal A., King B.A., Neff L.J., Whitmill J., Babb S.D. Graffunder C.M. Current cigarette smoking among adults-united states, 2005-2015. MMWR Morb. Mortal. Wkly. Rep. 2016;65(44):1205–1211.
  9. Prochaska J.J., Das S., Young-Wolff K.C. Smoking, Mental Illness, and Public Health. Annu. Rev. Public Health. 2017;38:165–185. https://doi.org/10.1146/annurev-publhealth-031816-044618
  10. Vital signs: current cigarette smoking among adults aged ≥18 years with mental illness – United States, 2009-2011. MMWR Morb. Mortal. Wkly. Rep. 2013;62(5):81–87.
  11. Holford T.R., Meza R., Warner K.E., Meernik C., Jeon J., Moolgavkar S.H., Levy D.T. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014;311(2):164–171. doi:10.1001/jama.2013.285112
  12. Hall F.S., Der-Avakian A., Gould T.J., Markou A., Shoaib M., Young J.W. Negative affective states and cognitive impairments in nicotine dependence. Neurosci. Biobehav. Rev. 2015;58:168–185. https://doi.org/10.1016/j.neubiorev.2015.06.004
  13.  Russell M.A.H., Peto J., Patel U.A. The Classification of smoking by factorial structure of motives  J. R. Stat. Soc. Ser. A Stat. Soc. 1974; Vol 137:313–346. https://doi.org/10.2307/2344953
  14. Wesnes K., Warburton D.M. Effects of smoking on rapid information processing performance. Neuropsychobiology. 1983;9(4):223–229.https://doi.org/10.1159/000117969
  15. Piper M.E., Piasecki T.M., Federman E.B., Bolt D.M., Smith S.S., Fiore M.C., Baker T.B. A multiple motives approach to tobacco dependence: The wisconsin inventory of smoking dependence motives (WISDM-68). J. Consult. Clin. Psychol. 2004;72(2):139–154. https://doi.org/10.1037/0022-006X.72.2.139
  16. Hatsukami D.K., Hughes J.R., Pickens R.W., Svikis D. Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology (Berl.) 1984;84(2):231–236. https://doi.org/10.1007/BF00427451
  17.   Alhowail A. Molecular insights into the benefits of nicotine on memory and cognition. Molecular medicine reports. 2021 Jun 1;23(6):1-6. https://doi.org/10.3892/mmr.2021.12037
  18. Lucchiari C, Masiero M, Mazzocco K, Veronesi G, Maisonneuve P, Jemos C, Salè EO, Spina S, Bertolotti R, Pravettoni G. Benefits of e-cigarettes in smoking reduction and in pulmonary health among chronic smokers undergoing a lung cancer screening program at 6 months. Addictive behaviors. 2020 Apr 1;103:106222. https://doi.org/10.1016/j.addbeh.2019.106222
  19. Pribadi F, Santosa RI, Darmanto AG. a review on nicotine for health: insight for “pro-health” nicotine usage. http://dspace.uc.ac.id/handle/123456789/2877
  20. Kim K, Niederdeppe J, Kalaji M, Scolere L, Porticella N, Mathios A, Avery R, Dorf M, Greiner Safi A, Byrne S. Contingent Effects of E-Cigarette Warning Label Messages on Cognitive Elaboration and Fear Among US Youth Ages 14–17 by Vaping Experience and Peer Vaping Behavior. Health Communication. 2024 Aug 25:1-3 https://doi.org/10.1080/10410236.2024.2394260 .
  21. Romijnders, K. A. G. J., Pennings, J. L. A., van Osch, L., de Vries, H., & Talhout, R. (2019). A Combination of Factors Related to Smoking Behavior, Attractive Product Characteristics, and Socio-Cognitive Factors are Important to Distinguish a Dual User from an Exclusive E-Cigarette User. International Journal of Environmental Research and Public Health, 16(21), 4191. https://doi.org/10.3390/ijerph16214191
  22. Record, R. A., Groznik, M., & Sussman, M. (2023). Communicative Processes Underlying DIY eJuice Mixing Among Young Adult International ENDS Users. Health Communication, 39(4), 666–674. https://doi.org/10.1080/10410236.2023.2179718
  23. Santos CP, Proença M, dos Santos Gouveia T, de Oliveira CB, Tacao GY, Trevisan IB, Ramos EM, Ramos D. Effectiveness of aerobic exercise on smoking cessation in adults: a systematic review and meta-analysis. Journal of Physical Activity and Health. 2021 Jan 12;18(2):230-42. DOI: https://doi.org/10.1123/jpah.2019-0339
Ahead of Print Subscription Original Research
Volume
Received 12/12/2024
Accepted 11/01/2025
Published 20/01/2025
455